NASDAQ · Financial Statements
CymaBay Therapeutics, Inc. (CBAY) Financial Statements
$32.48
NASDAQ: CBAY
Market Cap $3.73B
Overview Financials Dividend CymaBay Therapeutics, Inc. most recently reported annual revenue of $31.0M, net profit of $-105.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $0 $0 $0 $0 $31.0M Operating Profit $-108.0M $-53.0M $-88.0M $-93.0M $-102.0M Net Profit $-102.0M $-49.0M $-93.0M $-119.0M $-105.0M EPS $-1.53 $-0.71 $-1.30 $-1.35 $-0.99 Op Margin — — — — -327.2%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $206.0M $154.0M $202.0M $142.0M $435.0M Total Liabilities $19.0M $11.0M $69.0M $106.0M $142.0M Cash $25.0M $28.0M $126.0M $20.0M $207.0M Borrowings $2.0M $2.0M $52.0M $91.0M $114.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-98.0M $-45.0M $-69.0M $-84.0M $-73.0M Investing Cash Flow $-35.0M $48.0M $49.0M $-46.0M $-87.0M Financing Cash Flow $108.0M $0 $118.0M $25.0M $346.0M Net Cash Flow $-24.0M $3.0M $98.0M $-106.0M $186.0M Free Cash Flow $-98.0M $-45.0M $-70.0M $-84.0M $-73.0M
Valuation & Return Ratios
Metric Value PEG Ratio -1.11 EV / EBITDA -42.41 FCF Yield -1.96% Quick Ratio 10.96 Interest Coverage -5.37 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock